Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Abstract The 5-2-1 criteria was developed to facilitate the identification and referral of patients with Parkinson’s Disease (PD) inadequately controlled by oral medications. The criterion was not developed to screen patients with PD for device-aided therapy eligibility. The robust design and valida...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Angelo Antonini, K. Ray Chaudhuri, Josefa Domingos, Joohi Jimenez-Shahed, Jack Wright, Connie H. Yan, Ali Alobaidi, Lars Bergmann, Koray Onuk, Linda Harmer, Irene A. Malaty
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2024-07-01
Цуврал:	BMC Neurology
Нөхцлүүд:	Advanced Parkinson’s disease Device-aided therapies Patient identification 5-2-1 criteria Screening performance
Онлайн хандалт:	https://doi.org/10.1186/s12883-024-03691-3
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!